- Home
- NRSN vs MIND Comparison
NRSN vs MIND Comparison
Compare NRSN & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- MIND
- Stock Information
- Founded
- NRSN 2017
- MIND 1987
- Country
- NRSN Israel
- MIND United States
- Employees
- NRSN N/A
- MIND N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- MIND Industrial Machinery/Components
- Sector
- NRSN Health Care
- MIND Industrials
- Exchange
- NRSN Nasdaq
- MIND Nasdaq
- Market Cap
- NRSN 50.1M
- MIND 49.6M
- IPO Year
- NRSN 2021
- MIND 1994
- Fundamental
- Price
- NRSN $1.74
- MIND $9.58
- Analyst Decision
- NRSN Buy
- MIND
- Analyst Count
- NRSN 2
- MIND 0
- Target Price
- NRSN $14.00
- MIND N/A
- AVG Volume (30 Days)
- NRSN 225.6K
- MIND 202.9K
- Earning Date
- NRSN 08-05-2025
- MIND 09-10-2025
- Dividend Yield
- NRSN N/A
- MIND N/A
- EPS Growth
- NRSN N/A
- MIND N/A
- EPS
- NRSN N/A
- MIND 2.91
- Revenue
- NRSN N/A
- MIND $45,087,000.00
- Revenue This Year
- NRSN N/A
- MIND $7.27
- Revenue Next Year
- NRSN N/A
- MIND N/A
- P/E Ratio
- NRSN N/A
- MIND $3.36
- Revenue Growth
- NRSN N/A
- MIND 26.68
- 52 Week Low
- NRSN $0.60
- MIND $3.05
- 52 Week High
- NRSN $2.60
- MIND $11.10
- Technical
- Relative Strength Index (RSI)
- NRSN 39.25
- MIND 70.05
- Support Level
- NRSN $1.69
- MIND $7.12
- Resistance Level
- NRSN $2.09
- MIND $10.12
- Average True Range (ATR)
- NRSN 0.15
- MIND 0.48
- MACD
- NRSN -0.04
- MIND 0.20
- Stochastic Oscillator
- NRSN 17.78
- MIND 84.16
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.